The Premenstrual Syndrome and Menstrual Health Supplements market is expected to grow from an estimated USD 24.51 billion in 2024 to USD 42.12 billion in 2033, at a CAGR of 6.20%. Premenstrual syndrome (PMS) is characterized by physical and psychological symptoms that occur clinically during the luteal phase of the menstrual cycle and cause substantial anguish and functional impairment....